Fundraising Fox

OS Therapies

NYSE: OSTX

Grasonville, US · Founded 2018 · Delaware corporation · 1 known investors

ostherapies.com ↗
BiotechHealthtechin /os-therapies@OSTherapies

Founders & leadership

PA
Paul A. RomnessFounder, Chairman, President and Chief Executive Officer
CP
Christopher P. AcevedoChief Financial Officer
RG
Robert G. PetitChief Medical Officer and Chief Scientific Officer
GC
Gerald CommissiongChief Business Officer
AM
Avril McKean DieserDirector
CE
Craig EagleDirector
JC
John CiccioDirector
TF
Theodore F. SearchDirector
OR
Olivier R. JarryDirector

Investors · 1

K20 FundValley Stream · $100K – $2.5M

Reported raises · per SEC filings

Form D private placements
▶$1.6MraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)
OS Therapies Ends At-The-Market Equity Sales Program - TipRanks.comtipranks.com · Jul 2026OS Therapies Reports First Quarter 2026 Financials and Provides Business Update - BioSpacebiospace.com · May 2026
Officers, directors & promoters on the filing
  • Paul A. RomnessExecutive Officer, Director
  • Robert G. PetitExecutive Officer
  • Christopher P. AcevedoExecutive Officer
  • John CiccioDirector
  • Avril McKean DieserDirector
  • Craig EagleDirector
  • Olivier JarryDirector
  • Theodore F. SearchDirector
Offering amount
$9.3M
Amount sold
$1.6M
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore F. SearchDirector
  • Paul A. RomnessExecutive Officer, Director
  • Karim GalzahrDirector
  • Olivier JarryDirector
  • Christopher P. AcevedoExecutive Officer
  • John CiccioDirector
  • Avril McKean DieserDirector
  • Robert G. PetitExecutive Officer
Offering amount
$2M
Amount sold
$2M
Sales commissions
$140K
Placement agents
Ceros Financial Services, Inc.
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedJan 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John CiccioDirector
  • Avril McKean DieserDirector
  • Olivier JarryDirector
  • Christopher P. AcevedoExecutive Officer
  • Theodore F. SearchDirector
  • Robert G. PetitExecutive Officer
  • Karim GalzahrDirector
  • Paul A. RomnessExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$3.5M
Sales commissions
$627.5K
Placement agents
Ceros Financial Services, Inc.
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedSep 2025 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul A. RomnessExecutive Officer, Director
  • Avril McKean DieserDirector
  • Christopher P. AcevedoExecutive Officer
  • Karim GalzahrDirector
  • Robert G. PetitExecutive Officer
  • John CiccioDirector
  • Theodore F. SearchDirector
  • Olivier JarryDirector
Offering amount
$3.8M
Amount sold
$3.8M
Sales commissions
$56.7K
Placement agents
Ceros Financial Services, Inc.
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedJul 2025 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John CiccioDirector
  • Olivier JarryDirector
  • Karim GalzahrDirector
  • Paul A. RomnessExecutive Officer, Director
  • Robert G. PetitExecutive Officer
  • Christopher P. AcevedoExecutive Officer
  • Theodore F. SearchDirector
  • Avril McKean DieserDirector
Offering amount
$4.2M
Amount sold
$4.2M
Sales commissions
$210.8K
Placement agents
Ceros Financial Services, Inc.
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.1MraisedJan 2025 · 34 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Avril McKean DieserDirector
  • John CiccioDirector
  • Christopher P. AcevedoExecutive Officer
  • Theodore F. SearchDirector
  • Paul A. RomnessExecutive Officer, Director
  • Robert G. PetitExecutive Officer
  • Gerald CommissiongExecutive Officer
  • Olivier R. JarryDirector
Offering amount
$10M
Amount sold
$7.1M
Minimum investment
$10K
Sales commissions
$240K
Placement agents
Arcadia Securities, LLC, Ceros Financial Services, Inc.
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$700KraisedDec 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul A. RomnessExecutive Officer, Director
  • Colin GoddardDirector
  • Theodore F. SearchDirector
  • Joacim BorgDirector
  • Christopher P. AcevedoExecutive Officer
  • Robert G. PetitExecutive Officer
  • John CiccioDirector
Offering amount
$2M
Amount sold
$700K
Minimum investment
$50K
Sales commissions
$70K
Placement agents
Ceros Financial Services, Inc.
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJan 2023 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Joacim BorgDirector
  • Colin GoddardDirector
  • Jutta WannerExecutive Officer
  • Theodore SearchDirector
  • Christopher AcevedoExecutive Officer
  • John CiccioDirector
  • Robert PetitExecutive Officer
  • Paul RomnessExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
Minimum investment
$50K
Placement agents
Noble Capital Markets, Inc.
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news